Intra Cellular Therapies shares owned by 1492 Capital Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by 1492 Capital Management
from 13F filings
Historical chart of 1492 Capital Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by 1492 Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by 1492 Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.4M | 35k | 69.20 |
| 2023-12-31 | $2.5M | 35k | 71.62 |
| 2023-09-30 | $1.8M | 35k | 52.09 |
| 2023-06-30 | $2.2M | 35k | 63.32 |
| 2023-03-31 | $1.9M | 35k | 54.15 |
| 2022-12-31 | $1.9M | 35k | 52.92 |
| 2022-09-30 | $1.6M | 35k | 46.54 |
| 2022-06-30 | $1.4M | 24k | 57.08 |